CLINICAL_TRIALS trial_result · 2021-10-28

Clinical Trial Update: Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

A completed clinical trial evaluating the impact of early initiation of biological treatment for Ankylosing Spondylitis, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Ankylosing Spondylitis | Status: COMPLETED | Results posted: 2021-10-28